Kinder- und Jugendmedizin 2014; 14(02): 107-112
DOI: 10.1055/s-0038-1629382
Infektiologie
Schattauer GmbH

Enterovirus- und Parechovirus-Infektionen im Neugeborenenalter

Neonatal entovirus and parechovirus infections
M. Enders
1   Labor Prof. G. Enders und Kollegen, MVZ und Institut für Virologie, Infektiologie und Epidemiologie e. V., Stuttgart
,
L. von Müller
2   Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum des Saarlandes, Homburg/Saar
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Eingereicht am:22. November 2013

angenommen am:04. Dezember 2013

Publikationsdatum:
31. Januar 2018 (online)

Zusammenfassung

Enteroviren (EV) und humane Parechoviren (HPeV) sind nahe Verwandte aus der Familie der Picornaviridae und verursachen meist asymptomatisch oder mild verlaufende Infektionen. In der Neugeborenenperiode können sie aber durchaus zu schweren Erkrankungen mit Sepsis-ähnlichem Bild, Meningitis, Myokarditis und Multiorganversagen führen. Eine spezifische Therapie oder Impfung ist bislang nicht möglich. Die schnelle Diagnostik mit molekulargenetischen Schnelltests ist wichtig, um unnötige antibiotische Therapien zu reduzieren und um frühzeitig Hygiene- und Isolationsmaßnahmen einzuleiten.

Summary

Enterovirus (EV) and human Parechovirus (HPeV) are closely related members of the Picornavirus family. In the majority of cases mild or asymptomatic infections can be found; however, in the neonatal period also severe sepsis-like disease, meningitis, myocarditis and multiorgan failure may occur. Until today neither specific therapy nor vaccination is available but early diagnosis is required to avoid unnecessary antibiotic therapy and to initial prevention strategies by appropriate hygiene management.

 
  • Literatur

  • 1 Ahmad S, Dalwai A, Al-Nakib W. Frequency of enterovirus detection in blood samples of neonates admitted to hospital with sepsis-like illness in Kuwait. J Med Virol 2013; 85: 1280-1285.
  • 2 Arie S. Polio outbreak leads to calls for a „vaccination ceasefire“ in Syria. BMJ 2013; 347: f6682
  • 3 Aviner S, Sofer D, Shulman LM. et al. Hemophagocytic Lymphohistiocytosis Associated With Parechovirus 3 Infection. Journal of pediatric hematology/oncology. Epub ahead of print
  • 4 Bachmaier N, Fusch C, Stenger RD. et al. Nonimmune hydrops fetalis due to enterovirus infection. European journal of obstetrics, gynecology, and reproductive biology 2009; 142: 83-84.
  • 5 Basso NG, Fonseca ME, Garcia AG. et al. Enterovirus isolation from foetal and placental tissues. Acta virologica 1990; 34: 49-57.
  • 6 Chang ML, Tsao KC, Huang CC. et al. Coxsackievirus B3 in human milk. The Pediatric infectious disease journal 2006; 25: 955-957.
  • 7 Cherry JD, Krogstad P. Enterovirus and Parechovirus Infections. Infectious Diseases of the Fetus and Newborn 2010. 7th Ed.. 756-799.
  • 8 Chow KC, Lee CC, Lin TY. et al. Congenital enterovirus 71 infection: a case study with virology and immunohistochemistry. Clin Infect Dis 2000; 31: 509-512.
  • 9 Freund MW, Kleinveld G, Krediet TG. et al. Prognosis for neonates with enterovirus myocarditis. Arch Dis Child Fetal Neonatal Ed 2010; 95: F206-212.
  • 10 Frisk G, Diderholm H. Increased frequency of coxsackie B virus IgM in women with spontaneous abortion. The Journal of infection 1992; 24: 141-145.
  • 11 Harvala H, McLeish N, Kondracka J. et al. Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type. J Med Virol 2011; 83: 889-896.
  • 12 Harvala H, Robertson I, Chieochansin T. et al. Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. J Infect Dis 2009; 199: 1753-1760.
  • 13 Harvala H, Wolthers KC, Simmonds P. Parechoviruses in children: understanding a new infection. Curr Opin Infect Dis 2010; 23: 224-230.
  • 14 Hawkes MT, Vaudry W. Nonpolio enterovirus infection in the neonate and young infant. Paediatrics & child health 2005; 10: 383-388.
  • 15 Maus MV, Posencheg MA, Geddes K. et al. Detection of echovirus 18 in human breast milk. J Clin Microbiol 2008; 46: 1137-1140.
  • 16 Metzger C, Terletskaia-Ladwig E, Hess RD, Enders G. [Rational and efficient enterovirus diagnosis]. Dtsch Med Wochenschr 2001; 126: 289-293.
  • 17 Meyer S, Gortner L, Gottschling S, Gartner B, Abdul-Khaliq H. Cardiogenic shock in a neonate with enterovirus myocarditis. Klin Padiatr 2009; 221: 444-447.
  • 18 Nielsen AC, Bottiger B, Midgley SE, Nielsen LP. A novel enterovirus and parechovirus multiplex one-step real-time PCR-validation and clinical experience. Journal of virological methods 2013; 193: 359-363.
  • 19 Nielsen AC, Gyhrs ML, Nielsen LP. et al. Gastroenteritis and the novel picornaviruses aichi virus, cosavirus, saffold virus, and salivirus in young children. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013; 57: 239-242.
  • 20 Niklasson B, Samsioe A, Papadogiannakis N. et al Zoonotic Ljungan virus associated with central nervous system malformations in terminated pregnancy. Birth defects research. Part A. Clinical and molecular teratology 2009; 85: 542-545.
  • 21 Ogilvie MM, Tearne CF. Spontaneous abortion after hand-foot-and-mouth disease caused by Coxsackie virus A16. British medical journal 1980; 281: 1527-1528.
  • 22 Reyes MP, Zalenski D, Smith F. et al. Coxsackievirus-positive cervices in women with febrile illnesses during the third trimester in pregnancy. American journal of obstetrics and gynecology 1986; 155: 159-161.
  • 23 Roth B, Enders M, Arents A. et al. Epidemiologic aspects and laboratory features of enterovirus infections in Western Germany, 2000-2005. J Med Virol 2007; 79: 956-962.
  • 24 Samsioe A, Papadogiannakis N, Hultman T. et al. Ljungan virus present in intrauterine fetal death diagnosed by both immunohistochemistry and PCR. Birth defects research. Part A, Clinical and molecular teratology 2009; 85: 227-229.
  • 25 Sawyer MH. Enterovirus infections: diagnosis and treatment. Curr Opin Pediatr 2001; 13: 65-69.
  • 26 Schlapbach LJ, Ersch J, Balmer C. et al. Enteroviral myocarditis in neonates. Journal of paediatrics and child health 2013; 49: E451-454.
  • 27 Tauriainen S, Oikarinen S, Taimen K. et al. Temporal relationship between human parechovirus 1 infection and otitis media in young children. J Infect Dis 2008; 198: 35-40.
  • 28 Terletskaia-Ladwig E, Meier S, Hahn R. et al. A convenient rapid culture assay for the detection of enteroviruses in clinical samples: comparison with conventional cell culture and RT-PCR. Journal of medical microbiology 2008; 57: 1000-1006.
  • 29 van de Ven AA, Douma JW, Rademaker C. et al. Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia. Antiviral therapy 2011; 16: 611-614.
  • 30 Verboon-Maciolek MA, Krediet TG, Gerards LJ. et al. Severe neonatal parechovirus infection and similarity with enterovirus infection. The Pediatric infectious disease journal 2008; 27: 241-245.
  • 31 von Müller L, Diedrich S, Gärtner B. Enterovirusinfektionen (ohne Poliomyelitis). DGPI Handbuch. 2013. (6. Aufl) 246-248.
  • 32 Westerhuis B, Kolehmainen P, Benschop K. et al. Human parechovirus seroprevalence in Finland and the Netherlands. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 2013; 58: 211-215.
  • 33 Westerhuis BM, Jonker SC, Mattao S. et al. Growth characteristics of human parechovirus 1 to 6 on different cell lines and cross- neutralization of human parechovirus antibodies: a comparison of the cytopathic effect and real time PCR. Virology journal 2013; 10: 146
  • 34 Wildenbeest JG, Harvala H, Pajkrt D, Wolthers KC. The need for treatment against human parechoviruses: how, why and when?. Expert review of anti-infective therapy 2010; 8: 1417-1429.
  • 35 Wildenbeest JG, Wolthers KC, Straver B, Pajkrt D. Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant. Pediatrics 2013; 132: e243-247.
  • 36 Wolthers KC, Benschop KS, Schinkel J. et al. Human parechoviruses as an important viral cause of sepsislike illness and meningitis in young children. Clin Infect Dis 2008; 47: 358-363.
  • 37 Yuzurihara SS, Ao K Hara T, Tanaka F. et al. Human parechovirus-3 infection in nine neonates and infants presenting symptoms of hemophagocytic lymphohistiocytosis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2013; 19: 144-148.